Background: Nebulised medicines contribute to the high treatment burden experienced by patients with cystic fibrosis (CF).
Objectives: This study explored experiences of adult patients with CF when using nebulised medicines, factors impacting on their adherence to nebulised therapy and strategies they used to facilitate adherence.
Setting: Community setting, in Sydney, Australia.